Correlation Between Vytrus Biotech and Biotechnology Assets
Can any of the company-specific risk be diversified away by investing in both Vytrus Biotech and Biotechnology Assets at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vytrus Biotech and Biotechnology Assets into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vytrus Biotech SA and Biotechnology Assets SA, you can compare the effects of market volatilities on Vytrus Biotech and Biotechnology Assets and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vytrus Biotech with a short position of Biotechnology Assets. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vytrus Biotech and Biotechnology Assets.
Diversification Opportunities for Vytrus Biotech and Biotechnology Assets
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vytrus and Biotechnology is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Vytrus Biotech SA and Biotechnology Assets SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Assets and Vytrus Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vytrus Biotech SA are associated (or correlated) with Biotechnology Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Assets has no effect on the direction of Vytrus Biotech i.e., Vytrus Biotech and Biotechnology Assets go up and down completely randomly.
Pair Corralation between Vytrus Biotech and Biotechnology Assets
Assuming the 90 days trading horizon Vytrus Biotech SA is expected to under-perform the Biotechnology Assets. But the stock apears to be less risky and, when comparing its historical volatility, Vytrus Biotech SA is 1.39 times less risky than Biotechnology Assets. The stock trades about -0.13 of its potential returns per unit of risk. The Biotechnology Assets SA is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Biotechnology Assets SA on August 28, 2024 and sell it today you would earn a total of 3.00 from holding Biotechnology Assets SA or generate 9.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vytrus Biotech SA vs. Biotechnology Assets SA
Performance |
| Timeline |
| Vytrus Biotech SA |
| Biotechnology Assets |
Vytrus Biotech and Biotechnology Assets Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vytrus Biotech and Biotechnology Assets
The main advantage of trading using opposite Vytrus Biotech and Biotechnology Assets positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vytrus Biotech position performs unexpectedly, Biotechnology Assets can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Assets will offset losses from the drop in Biotechnology Assets' long position.| Vytrus Biotech vs. Cellnex Telecom SA | Vytrus Biotech vs. Plasticos Compuestos SA | Vytrus Biotech vs. Tier1 Technology SA | Vytrus Biotech vs. Hispanotels Inversiones SOCIMI |
| Biotechnology Assets vs. Laboratorios Farmaceuticos ROVI | Biotechnology Assets vs. Atrys Health SL | Biotechnology Assets vs. Oryzon Genomics SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |